EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access

Investigating the Immune Effects of Radiotherapy in Non-Small Cell Lung Cancer—Results of the PD-RAD Study

Shuhui Cheng, Tiana Kordbacheh, Antonia Banyard, Anshuman Chaturvedi, Diego Sanchez Martinez, Crispin T Hiley, Maggie Harris, Clara Chan, Corinne Faivre-Finn, Timothy M Illidge, Eleanor J Cheadle

Oncology Research · 2026

DOI: 10.32604/or.2025.072053 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Oncology Research, 2026. Verfasst von Shuhui Cheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Targeted Therapy Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, M…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The PACIFIC trial established the benefit of durvalumab following chemo-radiotherapy for stage III non-small cell lung cancer (NSCLC). However, the concurrent use of radiotherapy (RT) and durvalumab (PACIFIC-2 trial) showed no additional advantage. The PD-RAD study was set up to understand the immunological effects of RT on the tumor microenvironment (TME) to aid in optimizing sequencing of combination therapies.

Methods

The PD-RAD trial (ClinicalTrials.gov identifier: NCT03258788) aimed to enroll thirty NSCLC patients receiving radical-intent RT. Tumor biopsies and blood samples were collected pre-RT and at week 2 during RT and analyzed using multiplex immunohistochemistry (mIHC) and high-dimensional mass cytometry (CyTOF), respectively.

Results

Paired biopsies were collected from only three patients (Pts 1, 3 & 4) and blood from four patients (Pts 1-4) before the study was closed early during the COVID-19 pandemic. Programmed Death-Ligand 1 (PD-L1) expression in the TME was raised in Patient 1, who responded well to treatment, and unaltered in two patients with progressive disease. CyTOF analysis revealed elevated circulating classical monocytes, highest in the patient with a good response. Conclusions: macrophages in the TME and classical monocytes in the blood as potential immune biomarkers of RT response, but larger studies are needed to validate these observations and characterize the immune changes following curative-intent RT in patients with NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsAgedFemaleHumansMaleMiddle AgedAntibodies, MonoclonalB7-H1 AntigenChemoradiotherapyTumor Microenvironment

Stichwörter der Autor:innen

Non-small cell lung cancer (NSCLC)biomarkerclassical monocytesprogrammed death-ligand 1 (PD-L1)radiotherapytumor microenvironment

Substanzen

Antibodies, MonoclonalB7-H1 AntigenCD274 protein, humandurvalumab

Autor:innen und Institutionen

  • Targeted Therapy Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M20 4BX, UK.
  • Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK.
  • The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.
  • University College London Hospitals NHS Foundation Trust, London, WC1E 6AG, UK.
  • Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, WC1E 6BT, UK.

Zitieren

APA

Cheng, S., Kordbacheh, T., Banyard, A., Chaturvedi, A., Sanchez Martinez, D., Hiley, C. T., Harris, M., Chan, C., Faivre-Finn, C., Illidge, T. M., & Cheadle, E. J. (2026). Investigating the Immune Effects of Radiotherapy in Non-Small Cell Lung Cancer—Results of the PD-RAD Study. Oncology Research. https://doi.org/10.32604/or.2025.072053

Vancouver

Cheng S, Kordbacheh T, Banyard A, Chaturvedi A, Sanchez Martinez D, Hiley CT, et al. Investigating the Immune Effects of Radiotherapy in Non-Small Cell Lung Cancer—Results of the PD-RAD Study. Oncology Research. 2026. doi:10.32604/or.2025.072053

BibTeX
@article{Cheng2026,
  author = {Cheng, Shuhui and Kordbacheh, Tiana and Banyard, Antonia and Chaturvedi, Anshuman and Sanchez Martinez, Diego and Hiley, Crispin T and Harris, Maggie and Chan, Clara and Faivre-Finn, Corinne and Illidge, Timothy M and Cheadle, Eleanor J},
  title = {Investigating the Immune Effects of Radiotherapy in Non-Small Cell Lung Cancer—Results of the PD-RAD Study},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2025.072053}
}
Kostenlos starten →